Paolo Fiorina, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Effect of SARSCoV2 (COVID-19) Vaccination in Type 1 Diabetes (CoVaxT1D) (NCT04905823) | Paolo Fiorina, MD | 2021-03-31 |
Track Paolo Fiorina, MD automatically
Every clearance here is in the API, with alerts when new ones post.